Skip to content
Clinical Trials – home
Bicycletx Limited
Sponsor

Bicycletx Limited

United Kingdom Portway Building, Granta Park, Great Abington, CB21 6GS, United Kingdom

About the sponsor

Bicycletx Limited focuses on advanced malignancies across multiple solid-tumor settings, with research centred on cancers that express specific tumor-associated targets.

  • Advanced solid tumors
  • Metastatic cancer
  • Tumor-targeted oncology

Its clinical portfolio includes studies in advanced breast cancer, non-small cell lung cancer, and other difficult-to-treat malignant diseases.

About Specializations

Bicycletx Limited runs clinical trials in conditions such as Transitional cell carcinoma, Non-small cell lung cancer stage IV, Non-small cell lung cancer metastatic, Breast cancer, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

6 clinical trials

Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Bicycletx Limited
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:ZELENECTIDE PEVEDOTIN
  • Sponsor:Bicycletx Limited
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:ZELENECTIDE PEVEDOTIN
  • Sponsor:Bicycletx Limited
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Bicycletx Limited
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Bicycletx Limited
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Bicycletx Limited

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.